Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.

ABSTRACT: During cancer progression, malignant cells undergo epithelial-mesenchymal transitions (EMT) and mesenchymal-epithelial transitions (MET) as part of a broad invasion and metastasis program. We previously observed MET events among lung metastases in a preclinical model of prostate adenocarcinoma that suggested a relationship between epithelial plasticity and metastatic spread. We thus sought to translate these findings into clinical evidence by examining the existence of EMT in circulating tumor cells (CTC) from patients with progressive metastatic solid tumors, with a focus on men with castration-resistant prostate cancer (CRPC) and women with metastatic breast cancer. We showed that the majority (> 80%) of these CTCs in patients with metastatic CRPC coexpress epithelial proteins such as ep

SUBMITTER: Armstrong AJ 

PROVIDER: S-EPMC3157566 | biostudies-literature | 2011 Aug

REPOSITORIES: biostudies-literature